Get started
Work

Late Breaking Abstract - Safety and tolerability of nerandomilast in patients with pulmonary fibrosis: pooled data from the FIBRONEER-IPF and FIBRONEER-ILD trials

Year: 2025
Type: conference-abstract
DOI: 10.1183/13993003.congress-2025.pa2977
Authors: Justin M Oldham, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Toby M Maher, Luca Richeldi, Claudia Valenzuela, Marlies S. Wijsenbeek, Daniel Wachtlin, Gerrit Weimann, Ivana Ritter, Donald F Zoz, Fernando J Martinez
Institutions: University of Michigan, The University of Texas Health Science Center at Houston, Nippon Medical School, Lyon 1 Université, Hospices Civils de Lyon, Hôpital Louis Pradel, Oslo University Hospital, University of Zurich, University Hospital Zurich, University Medical Center of the Johannes Gutenberg University Mainz, University of Southern California, Imperial College London, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Erasmus MC, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States), University of Massachusetts Chan Medical School, UMass Memorial Medical Center
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4416637514
Cites:
Cited by:
Related to: 10